3. Xia N, Daiber A, Forstermann U, et al. Antioxidant effects of resveratrol in the cardiovascular system. Br J Pharmacol. 2017;174:1633-1646.
4.
Li XN, Ma LY, Ji H, et al. Resveratrol protects against oxidative stress by activating the Keap-1/Nrf2 antioxidant defense system in obese-asthmatic rats. Exp Ther Med. 2018;16:4339-4348.
5. Baur JA, Sinclair DA. Therapeutic potential of resveratrol: the in vivo
evidence.Nat Rev Drug Discov. 2006;5:493-506.
6. Satoh A, Brace CS, Rensing N, et al. Sirt1 extends life span and delays aging in mice through the regulation of Nk2 homeobox 1 in the DMH and LH. Cell Metab. 2013;18: 416-430.
7. 8.
Bai X, Yao L, Ma X, et al. Small molecules as SIRT modulators. Mini Rev Med Chem. 2018;18:1151-1157.
Bhullar KS, Hubbard BP. Lifespan and healthspan extension by
resveratrol.Biochim Biophys Acta. 2015;1852(6): 1209-1218.
9. Agarwal B, Baur JA. Resveratrol and life extension. Ann N Y Acad Sci. 2011;1215:138-143.
10. Burns J, Yokota T, Ashihara H, et al. Plant foods and herbal sources of resveratrol. J Agric Food Chem. 2002;50: 3337-3340.
11. EFSA Panel on Dietetic Products. Safety of synthetic trans- resveratrol as a novel food pursuant to Regulation (EC) No 258/97.EFSA J. 2016;14(1):4368.
12. Ramirez-Garza SL, Laveriano-Santos EP, Marhuenda- Munoz M, et al. Health effects of resveratrol: results from human intervention trials. Nutrients. 2018;10(12):1892.
13. Walle T. Bioavailability of resveratrol.Ann N Y Acad Sci. 2011;1215:9-15.
14. Boocock DJ, Faust GES, Patel KR, et al. Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1246-1252.
15. Elliott PJ, Jirousek M. Sirtuins: novel targets for metabolic disease. Curr Opin Investig Drugs. 2008;9:371-378.
16. Neves AR, Lucio M, Lima JL, et al. Resveratrol in medicinal chemistry: a critical review of its pharmacokinetics, drug- delivery, and membrane interactions. Curr Med Chem. 2012;19:1663-1681.
17. Chen H, Tuck T, Ji X, et al. Quality assessment of Japanese knotweed (Fallopia japonica) grown on Prince Edward Island as a source of resveratrol. J Agric Food Chem. 2013;61:6383-6392.
18. Stervbo U, Vang O, Bonnesen C. A review of the content of the putative chemopreventive phytoalexin resveratrol in red wine. Food Chem. 2007;101:449-457.
19. Navarro G, Martínez-Pinilla E, Ortiz R, et al. Resveratrol and related stilbenoids, nutraceutical/dietary complements with health-promoting actions: industrial production, safety, and the search for mode of
action.Compr Rev Food Sci Food Saf. 2018;17:808-826.
20. Thapa SB, Pandey RP, Park YI, et al. Biotechnological advances in resveratrol production and its chemical diversity. Molecules. 2019;24:2571.
21. Wustenberg B, Stemmler RT, Letinois U, et al. Large-scale production of bioactive ingredients as supplements for healthy human and animal nutrition. Chimia (Aarau). 2011;65:420-428.
22. Resveratrol. Dietary Supplement Label Database. National Institutes of Health, Office of Dietary Supplements. December 2022. Accessed May 8, 2023.
https://dsld.od.nih.gov
23. Koga CC, Lee SY, Lee Y. Consumer acceptance of bars and gummies with unencapsulated and encapsulated resveratrol.J Food Sci. 2016;81:S1222-S1229.
24. Berman AY, Motechin RA, Wiesenfeld MY, et al. The therapeutic potential of resveratrol: a review of clinical
trials.NPJ Precis Oncol. 2017;1:35.
25. Shaito A, Posadino AM, Younes N, et al. Potential adverse effects of resveratrol: a literature review. Int J Mol Sci. 2020;21(6):2084.
26. Detampel P, Beck M, Krähenbühl S, et al. Drug interaction potential of resveratrol. Drug Metab Rev. 2012;44:253-265.
27. Huang TY, Yu CP, Hsieh YW, et al. Resveratrol stereoselectively affected (+/-)warfarin pharmacokinetics and enhanced the anticoagulation effect. Sci Rep. 2020;10:15910.
28. Cho S, Namkoong K, Shin M, et al. Cardiovascular protective effects and clinical applications of resveratrol.J Med Food. 2017;20:323-334.
29. Hausenblas HA, Schoulda JA, Smoliga JM. Resveratrol treatment as an adjunct to pharmacological management in type 2 diabetes mellitus—systematic review and meta-
analysis.Mol Nutr Food Res. 2015;59:147-159.
30. Abdollahi S, Salehi-Abargouei A, Toupchian O, et al. The effect of resveratrol supplementation on cardio-metabolic risk factors in patients with type 2 diabetes: a randomized, double-blind controlled trial. Phytother Res. 2019;33: 3153-3162.
31. Samsami-Kor M, Daryani NE, Asl PR, et al. Anti- inflammatory effects of resveratrol in patients with ulcerative colitis: a randomized, double-blind, placebo- controlled pilot study. Arch Med Res. 2015;46:280-285.
32. Tome-Carneiro J, Larrosa M, Yanez-Gascon MJ, et al. One- year supplementation with a grape extract containing resveratrol modulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease. Pharmacol Res. 2013;72:69-82.
33. Wong RH, Berry NM, Coates AM, et al. Chronic resveratrol consumption improves brachial flow-mediated dilatation in healthy obese adults. J Hypertens. 2013;31:1819-1827.
34. Wong RH, Howe PR, Buckley JD, et al. Acute resveratrol supplementation improves flow-mediated dilatation in overweight/obese individuals with mildly elevated blood pressure. Nutr Metab Cardiovasc Dis. 2011;21:851-856.
35. Zahedi HS, Jazayeri S, Ghiasvand R, et al. Effects of polygonum cuspidatum containing resveratrol on inflammation in male professional basketball players. Int J Prev Med. 2013;4:S1-S4.
36. Anton SD, Embry C, Marsiske M, et al. Safety and metabolic outcomes of resveratrol supplementation in older adults: results of a twelve-week, placebo-controlled pilot study. Exp Gerontol. 2014;57:181-187.
37. Hoseini A, Namazi G, Farrokhian A, et al. The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Food Funct. 2019;10:6042-6051.
38. Khodabandehloo H, Seyyedebrahimi S, Esfahani EN, et al. Resveratrol supplementation decreases blood glucose without changing the circulating CD14(+)CD16(+) monocytes and inflammatory cytokines in patients with type 2 diabetes: a randomized, double-blind, placebo- controlled study. Nutr Res. 2018;54:40-51.
504 HEALTH PROFESSIONALS GUIDE TO DIETARY SUPPLEMENTS
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88 |
Page 89 |
Page 90 |
Page 91 |
Page 92 |
Page 93 |
Page 94 |
Page 95 |
Page 96 |
Page 97 |
Page 98 |
Page 99 |
Page 100 |
Page 101 |
Page 102 |
Page 103 |
Page 104 |
Page 105 |
Page 106 |
Page 107 |
Page 108 |
Page 109 |
Page 110 |
Page 111 |
Page 112 |
Page 113 |
Page 114 |
Page 115 |
Page 116 |
Page 117 |
Page 118 |
Page 119 |
Page 120 |
Page 121 |
Page 122 |
Page 123 |
Page 124 |
Page 125 |
Page 126 |
Page 127 |
Page 128 |
Page 129 |
Page 130 |
Page 131 |
Page 132 |
Page 133 |
Page 134 |
Page 135 |
Page 136 |
Page 137 |
Page 138 |
Page 139 |
Page 140 |
Page 141 |
Page 142 |
Page 143 |
Page 144 |
Page 145 |
Page 146 |
Page 147 |
Page 148 |
Page 149 |
Page 150 |
Page 151 |
Page 152 |
Page 153 |
Page 154 |
Page 155 |
Page 156 |
Page 157 |
Page 158 |
Page 159 |
Page 160 |
Page 161 |
Page 162 |
Page 163 |
Page 164 |
Page 165 |
Page 166 |
Page 167 |
Page 168 |
Page 169 |
Page 170 |
Page 171 |
Page 172 |
Page 173 |
Page 174 |
Page 175 |
Page 176 |
Page 177 |
Page 178 |
Page 179 |
Page 180 |
Page 181 |
Page 182 |
Page 183 |
Page 184 |
Page 185 |
Page 186 |
Page 187 |
Page 188 |
Page 189 |
Page 190 |
Page 191 |
Page 192 |
Page 193 |
Page 194 |
Page 195 |
Page 196 |
Page 197 |
Page 198 |
Page 199 |
Page 200 |
Page 201 |
Page 202 |
Page 203 |
Page 204 |
Page 205 |
Page 206 |
Page 207 |
Page 208 |
Page 209 |
Page 210 |
Page 211 |
Page 212 |
Page 213 |
Page 214 |
Page 215 |
Page 216 |
Page 217 |
Page 218 |
Page 219 |
Page 220 |
Page 221 |
Page 222 |
Page 223 |
Page 224 |
Page 225 |
Page 226 |
Page 227 |
Page 228 |
Page 229 |
Page 230 |
Page 231 |
Page 232 |
Page 233 |
Page 234 |
Page 235 |
Page 236 |
Page 237 |
Page 238 |
Page 239 |
Page 240 |
Page 241 |
Page 242 |
Page 243 |
Page 244 |
Page 245 |
Page 246 |
Page 247 |
Page 248 |
Page 249 |
Page 250 |
Page 251 |
Page 252 |
Page 253 |
Page 254 |
Page 255 |
Page 256 |
Page 257 |
Page 258 |
Page 259 |
Page 260 |
Page 261 |
Page 262 |
Page 263 |
Page 264 |
Page 265 |
Page 266 |
Page 267 |
Page 268 |
Page 269 |
Page 270 |
Page 271 |
Page 272 |
Page 273 |
Page 274 |
Page 275 |
Page 276 |
Page 277 |
Page 278 |
Page 279 |
Page 280 |
Page 281 |
Page 282 |
Page 283 |
Page 284 |
Page 285 |
Page 286 |
Page 287 |
Page 288 |
Page 289 |
Page 290 |
Page 291 |
Page 292 |
Page 293 |
Page 294 |
Page 295 |
Page 296 |
Page 297 |
Page 298 |
Page 299 |
Page 300 |
Page 301 |
Page 302 |
Page 303 |
Page 304 |
Page 305 |
Page 306 |
Page 307 |
Page 308 |
Page 309 |
Page 310 |
Page 311 |
Page 312 |
Page 313 |
Page 314 |
Page 315 |
Page 316 |
Page 317 |
Page 318 |
Page 319 |
Page 320 |
Page 321 |
Page 322 |
Page 323 |
Page 324 |
Page 325 |
Page 326 |
Page 327 |
Page 328 |
Page 329 |
Page 330 |
Page 331 |
Page 332 |
Page 333 |
Page 334 |
Page 335 |
Page 336 |
Page 337 |
Page 338 |
Page 339 |
Page 340 |
Page 341 |
Page 342 |
Page 343 |
Page 344 |
Page 345 |
Page 346 |
Page 347 |
Page 348 |
Page 349 |
Page 350 |
Page 351 |
Page 352 |
Page 353 |
Page 354 |
Page 355 |
Page 356 |
Page 357 |
Page 358 |
Page 359 |
Page 360 |
Page 361 |
Page 362 |
Page 363 |
Page 364 |
Page 365 |
Page 366 |
Page 367 |
Page 368 |
Page 369 |
Page 370 |
Page 371 |
Page 372 |
Page 373 |
Page 374 |
Page 375 |
Page 376 |
Page 377 |
Page 378 |
Page 379 |
Page 380 |
Page 381 |
Page 382 |
Page 383 |
Page 384 |
Page 385 |
Page 386 |
Page 387 |
Page 388 |
Page 389 |
Page 390 |
Page 391 |
Page 392 |
Page 393 |
Page 394 |
Page 395 |
Page 396 |
Page 397 |
Page 398 |
Page 399 |
Page 400 |
Page 401 |
Page 402 |
Page 403 |
Page 404 |
Page 405 |
Page 406 |
Page 407 |
Page 408 |
Page 409 |
Page 410 |
Page 411 |
Page 412 |
Page 413 |
Page 414 |
Page 415 |
Page 416 |
Page 417 |
Page 418 |
Page 419 |
Page 420 |
Page 421 |
Page 422 |
Page 423 |
Page 424 |
Page 425 |
Page 426 |
Page 427 |
Page 428 |
Page 429 |
Page 430 |
Page 431 |
Page 432 |
Page 433 |
Page 434 |
Page 435 |
Page 436 |
Page 437 |
Page 438 |
Page 439 |
Page 440 |
Page 441 |
Page 442 |
Page 443 |
Page 444 |
Page 445 |
Page 446 |
Page 447 |
Page 448 |
Page 449 |
Page 450 |
Page 451 |
Page 452 |
Page 453 |
Page 454 |
Page 455 |
Page 456 |
Page 457 |
Page 458 |
Page 459 |
Page 460 |
Page 461 |
Page 462 |
Page 463 |
Page 464 |
Page 465 |
Page 466 |
Page 467 |
Page 468 |
Page 469 |
Page 470 |
Page 471 |
Page 472 |
Page 473 |
Page 474 |
Page 475 |
Page 476 |
Page 477 |
Page 478 |
Page 479 |
Page 480 |
Page 481 |
Page 482 |
Page 483 |
Page 484 |
Page 485 |
Page 486 |
Page 487 |
Page 488 |
Page 489 |
Page 490 |
Page 491 |
Page 492 |
Page 493 |
Page 494 |
Page 495 |
Page 496 |
Page 497 |
Page 498 |
Page 499 |
Page 500 |
Page 501 |
Page 502 |
Page 503 |
Page 504 |
Page 505 |
Page 506 |
Page 507 |
Page 508 |
Page 509 |
Page 510 |
Page 511 |
Page 512 |
Page 513 |
Page 514 |
Page 515 |
Page 516 |
Page 517 |
Page 518 |
Page 519 |
Page 520 |
Page 521 |
Page 522 |
Page 523 |
Page 524 |
Page 525 |
Page 526 |
Page 527 |
Page 528 |
Page 529 |
Page 530 |
Page 531 |
Page 532 |
Page 533 |
Page 534 |
Page 535 |
Page 536 |
Page 537 |
Page 538 |
Page 539 |
Page 540 |
Page 541 |
Page 542 |
Page 543 |
Page 544 |
Page 545 |
Page 546 |
Page 547 |
Page 548 |
Page 549 |
Page 550 |
Page 551 |
Page 552 |
Page 553 |
Page 554 |
Page 555 |
Page 556 |
Page 557 |
Page 558 |
Page 559 |
Page 560 |
Page 561 |
Page 562 |
Page 563 |
Page 564 |
Page 565 |
Page 566 |
Page 567 |
Page 568 |
Page 569 |
Page 570 |
Page 571 |
Page 572 |
Page 573 |
Page 574 |
Page 575 |
Page 576 |
Page 577 |
Page 578 |
Page 579 |
Page 580 |
Page 581 |
Page 582 |
Page 583 |
Page 584 |
Page 585 |
Page 586 |
Page 587 |
Page 588 |
Page 589 |
Page 590 |
Page 591 |
Page 592 |
Page 593 |
Page 594 |
Page 595 |
Page 596 |
Page 597 |
Page 598 |
Page 599 |
Page 600 |
Page 601 |
Page 602 |
Page 603 |
Page 604 |
Page 605 |
Page 606 |
Page 607 |
Page 608 |
Page 609 |
Page 610 |
Page 611 |
Page 612 |
Page 613 |
Page 614 |
Page 615 |
Page 616 |
Page 617 |
Page 618 |
Page 619 |
Page 620 |
Page 621 |
Page 622 |
Page 623 |
Page 624 |
Page 625 |
Page 626 |
Page 627 |
Page 628 |
Page 629 |
Page 630 |
Page 631 |
Page 632 |
Page 633 |
Page 634 |
Page 635 |
Page 636 |
Page 637 |
Page 638 |
Page 639 |
Page 640 |
Page 641 |
Page 642 |
Page 643 |
Page 644 |
Page 645 |
Page 646 |
Page 647 |
Page 648 |
Page 649 |
Page 650 |
Page 651 |
Page 652 |
Page 653 |
Page 654 |
Page 655 |
Page 656 |
Page 657 |
Page 658 |
Page 659 |
Page 660 |
Page 661 |
Page 662 |
Page 663 |
Page 664 |
Page 665 |
Page 666 |
Page 667 |
Page 668 |
Page 669 |
Page 670 |
Page 671 |
Page 672 |
Page 673 |
Page 674 |
Page 675 |
Page 676 |
Page 677 |
Page 678 |
Page 679 |
Page 680 |
Page 681 |
Page 682 |
Page 683 |
Page 684 |
Page 685 |
Page 686 |
Page 687 |
Page 688 |
Page 689 |
Page 690 |
Page 691 |
Page 692 |
Page 693 |
Page 694
